Jacobs IJ - Search Results

1

Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.

Skates SJ, Horick N, Yu Y, Xu FJ, Berchuck A, Havrilesky LJ, de Bruijn HW, van der Zee AG, Woolas RP, Jacobs IJ, Zhang Z, Bast RC Jr. Skates SJ, et al. Among authors: jacobs ij. J Clin Oncol. 2004 Oct 15;22(20):4059-66. doi: 10.1200/JCO.2004.03.091. Epub 2004 Sep 20. J Clin Oncol. 2004. PMID: 15381683

2

Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation.

Jacobs IJ, Kohler MF, Wiseman RW, Marks JR, Whitaker R, Kerns BA, Humphrey P, Berchuck A, Ponder BA, Bast RC Jr. Jacobs IJ, et al. J Natl Cancer Inst. 1992 Dec 2;84(23):1793-8. doi: 10.1093/jnci/84.23.1793. J Natl Cancer Inst. 1992. PMID: 1433368

3

Strategies for improving the specificity of screening for ovarian cancer with tumor-associated antigens CA 125, CA 15-3, and TAG 72.3.

Jacobs IJ, Oram DH, Bast RC Jr. Jacobs IJ, et al. Obstet Gynecol. 1992 Sep;80(3 Pt 1):396-9. Obstet Gynecol. 1992. PMID: 1495694

4

Combinations of multiple serum markers are superior to individual assays for discriminating malignant from benign pelvic masses.

Woolas RP, Conaway MR, Xu F, Jacobs IJ, Yu Y, Daly L, Davies AP, O'Briant K, Berchuck A, Soper JT, et al. Woolas RP, et al. Among authors: jacobs ij. Gynecol Oncol. 1995 Oct;59(1):111-6. doi: 10.1006/gyno.1995.1276. Gynecol Oncol. 1995. PMID: 7557595 Clinical Trial.

5

Differential diagnosis of ovarian cancer with tumour markers CA 125, CA 15-3 and TAG 72.3.

Jacobs IJ, Rivera H, Oram DH, Bast RC Jr. Jacobs IJ, et al. Br J Obstet Gynaecol. 1993 Dec;100(12):1120-4. doi: 10.1111/j.1471-0528.1993.tb15177.x. Br J Obstet Gynaecol. 1993. PMID: 8297846

6

Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer.

Kohler MF, Marks JR, Wiseman RW, Jacobs IJ, Davidoff AM, Clarke-Pearson DL, Soper JT, Bast RC Jr, Berchuck A. Kohler MF, et al. Among authors: jacobs ij. J Natl Cancer Inst. 1993 Sep 15;85(18):1513-9. doi: 10.1093/jnci/85.18.1513. J Natl Cancer Inst. 1993. PMID: 8360934

7

Elevation of multiple serum markers in patients with stage I ovarian cancer.

Woolas RP, Xu FJ, Jacobs IJ, Yu YH, Daly L, Berchuck A, Soper JT, Clarke-Pearson DL, Oram DH, Bast RC Jr. Woolas RP, et al. Among authors: jacobs ij. J Natl Cancer Inst. 1993 Nov 3;85(21):1748-51. doi: 10.1093/jnci/85.21.1748. J Natl Cancer Inst. 1993. PMID: 8411259

8

Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer.

Hurteau JA, Woolas RP, Jacobs IJ, Oram DC, Kurman CC, Rubin LA, Nelson DL, Berchuck A, Bast RC Jr, Mills GB. Hurteau JA, et al. Among authors: jacobs ij. Cancer. 1995 Nov 1;76(9):1615-20. doi: 10.1002/1097-0142(19951101)76:9<1615::aid-cncr2820760918>3.0.co;2-g. Cancer. 1995. PMID: 8635066 Clinical Trial.

9

Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study.

Jacobs IJ, Skates S, Davies AP, Woolas RP, Jeyerajah A, Weidemann P, Sibley K, Oram DH. Jacobs IJ, et al. BMJ. 1996 Nov 30;313(7069):1355-8. doi: 10.1136/bmj.313.7069.1355. BMJ. 1996. PMID: 8956699 Free PMC article. Clinical Trial.

10

Screening for ovarian cancer.

MacDonald ND, Rosenthal AN, Jacobs IJ. MacDonald ND, et al. Among authors: jacobs ij. Ann Acad Med Singap. 1998 Sep;27(5):676-82. Ann Acad Med Singap. 1998. PMID: 9919339 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

265 results

Search Page

Filters